Spring 2014 Thursday Seminar Series

All seminars will be held in 1131 Bioinformatics from 12:30pm-1:30pm

Jan. 9 Ru-Rong Ji, PhD - Duke University Glial and Immune Control of Pain and Synaptic Transmission
Jan. 14 Tues Joint CIDD/Neuroscience Center Seminar: Michela Fagiolini, PhD - Harvard University Neuronal Circuit Dissection and Recovery in the Absence of Mecp2
Jan. 23 Benjamin Deneen, PhD - Baylor University Patterning and Gliogenesis: A Journey through Space and Time in the CNS
Jan. 30 Student-Invited Seminar Series: Eric Nestler, MD, PhD - Mount Sinai Hospital Transcriptional and Epigenetics Mechanisms of Addiction

Feb. 6


Student-Invited Seminar Series: Gina Turrigiano, PhD - Brandeis University Self-tuning Neurons and Neural Circuit Stability

Feb. 13


Peter McKinnon, PhD - St.Jude Children's Research Hospital Genome Stability and the Prevention of Neurologic Disease
Feb. 20 Student-Invited Seminar Series: Marcus Raichle, MD - Washington University School of Medicine See Perl Prize
Feb. 27 Mike Bruchas, PhD - Washington University Dissecting GPCR function in Stress Neural Circuits and Affective Behaviors
Mar. 6 Philipp Keller, PhD - Janelia Research Farm Reconstructing Nervous System Development and Function Using Light-sheet Microscopy
Mar. 13 Mustafa Sahin, MD, PhD - Boston Children's Hospital Tuberous Sclerosis: Shedding Light on the Neural Circuitry of Autism

Mar. 18


Joint CIDD/Neuroscience Center Seminar: Stephan Sanders, PhD - Yale University

A Genetic Approach to Understanding the Etiology of Autism

Mar. 27 Angelique Bordey, PhD - Yale University Identifying and Rescuing Circuit Deficits in mTORopathy
Apr. 3 Maria Lehtinen, PhD - Harvard University Instructive Cues for Neural Stem Cells in the Cerebrospinal Fluid
Apr. 10 Lindsey Glickfeld, PhD - Duke University Target Specific Projections in Mouse visual Cortex
Apr. 17 Matt Dalva, PhD - Jefferson University Molecules that Guide Synapse Formation and Function
June 5 Jeffrey D. Rothstein, MD, PhD - Johns Hopkins Medicine C9orf72 and RNA Toxicity as the Cause of ALS/FTD: Human and Animal Models to Develop Molecular Therapies